Roche Holding Aktiengesellschaft operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Roche Holding Aktiengesellschaft with three other
pharmaceutical manufacturers in Europe:
sales of 48.29 billion Swiss Francs [US$53.01 billion]
of which 78%
was Innovative Medicines),
(37.63 billion Euros [US$44.22 billion]
of which 68%
was Pharmaceuticals), and
based in GERMANY
(43.55 billion Euros [US$51.17 billion]
of which 46%
Roche Holding Aktiengesellschaft reported sales of 61.47 billion Swiss Francs (US$67.47 billion)
December of 2019.
increase of 8.1%
versus 2018, when the company's sales were 56.85 billion Swiss Francs.
Sales at Roche Holding Aktiengesellschaft have increased during each of the previous five years
(and since 2014, sales have increased a total of 30%).
Sales of Pharmaceuticals saw an increase
10.3% in 2019, from
43.97 billion Swiss Francs to 48.52 billion Swiss Francs.